ClinicalTrials.gg
Status unknownNCT05058248DORECLIUpdated Mar 14, 2022

Evaluation of a Locoregional Anesthesia Protocol by Pudendal Block in Reconstructive Surgery Clitoral

An interventional study of pudendal block in Reduction in Pain Within 24 Hours of Surgery, sponsored by Raincy Montfermeil Hospital Group. Status unknown at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-03-14.

Sponsored by Raincy Montfermeil Hospital Group · Not applicable, Interventional, and Other

How we know

The sponsor has not verified this record recently (last verified Sep 2021), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Non-randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 135 studies in Chronic Pain with a site in France — 35 open to participants now, 39 under way, 2 of them phase 3. Chronic Pain · France.

Planned enrollment
34th of 67
78 · median 78
Started
2021
with 13 others
No phase
44 of 135
17 open now
Registered
83rd of 135
by date

Among the 135 studies in Chronic Pain with a site in France, this one is the 34th largest by planned enrollment of the 67 interventional ones that give a count, is one of 14 that started in 2021, is one of 44 with no phase, and was the 83rd registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

35 of the 135 studies in Chronic Pain with a site in France are open now. Recruiting first, the newest first:

30 more — sign in →

All 35 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 135 studies in Chronic Pain with a site in France, or all of them as a file.
02

Study summary

Reconstructive surgery of the clitoris is part of the care offered during a process of care of women victims of MSF. It consists in reconstituting a clitoral neogland after removal of the vulvar excisional scar and recovery of the remaining clitoris. Studies that have monitoring the implementation of this surgery show that it improves the well-being of the patients, brings benefits anatomically, sexual health, personal development, and in the long term decreases chronic pain.

Currently the standard method used in the usual care of the patient is: general anesthesia with an intravenous analgesic protocol then oral without anesthesia regional loco The pudendal block that the investigators want to evaluate in this research, is a technique that has made proven in several types of surgery, associated with very few complications and easily reproducible.

Read the detailed description

Reconstructive surgery of the clitoris is part of the care offered during a process of care of women victims of MSF. It consists in reconstituting a clitoral neogland after removal of the vulvar excisional scar and recovery of the remaining clitoris. Studies that have monitoring the implementation of this surgery show that it improves the well-being of the patients, brings benefits anatomically, sexual health, personal development, and in the long term decreases chronic pain. Currently the standard method used in the usual care of the patient is: general anesthesia with an intravenous analgesic protocol then oral without anesthesia regional loco The pudendal block that the investigators want to evaluate in this research, is a technique that has made proven in several types of surgery, associated with very few complications and easily reproducible. The human clitoris is the most sensitive organ in the human body, with over 8000 endings nervous. All these endings come from the pudendal nerve, itself most often of nerve roots S3. The main hypothesis is that a bilateral anesthetic block of this nerve would reduce postoperative pain in clitoral surgery

03

Conditions studied

  • Reduction in Pain Within 24 Hours of Surgery

Browse trials for

Keywords

  • excision
  • Reconstructive surgery of the clitoris
  • sexual health
  • chronic pain,
  • The pudendal block nerve endings.
  • postoperative pain in clitoral surgery
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Major patient,
  • With the indication of a clitoral repair surgery
  • Having expressed their free and informed written consent
  • Affiliated with a social security scheme

Exclusion criteria

Exclusion Criteria:

  • to the pudendal block technique: notably :
  • blood crass disorder
  • allergy to Naropein
  • infection at the injection site - Poor understanding of the interest of the practice proposed experimental
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
78 participants (estimated)

Study arms

  • Active comparator
    Pudendal block

    Ultrasound-guided bilateral pudendal block at the start of surgery, in gynecological position: injection of 15 mL of 0.475% Naropein in each ischiorectal fossa.

    Procedure: pudendal block

  • Other
    the standard method

    Operated and anesthetized patients according to the standard method within the department

    Procedure: pudendal block

Interventions

  • Procedurepudendal block

    general anesthesia with an intravenous analgesic protocol then oral without anesthesia regional loco

    Also known as: standard method

06

What researchers measure

Primary outcomes

  1. decrease in the mean of the self-reported pain scores in the first 24 hours

    decrease in the mean of the self-reported pain scores in the first 24 hours using a Numerical visual scale

    Time frame: 24 hours

Secondary outcomes

  1. decrease in pain on the EVN at 2 hours, 6 hours , Day 1 and Day 7 postoperative

    decrease in pain on the EVN at 2 hours, 6 hours , Day 1 and Day 7 with the pudental block method

    Time frame: 2 hours, 6 hours, Day 1 and Day 7 postoperative

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2021 (actual). Primary completion is estimated for Jan 2023, 15 months after the start.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 15 months is below that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 13, 2021
First posted
Sep 27, 2021
StartActual
Oct 14, 2021
Primary completionEst.
Jan 2023
CompletionEst.
Jan 2023
Last update
Mar 14, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 14, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05058248
Lead sponsor
Raincy Montfermeil Hospital Group
Responsible party
Sponsor
First posted
Sep 27, 2021
Start date
Oct 14, 2021
Primary completion
Jan 2023 (estimated)
Completion
Jan 2023 (estimated)
Last update
Mar 14, 2022

Study contacts

Mathieux CAMBY, MD
Contact
mathieu.camby@ght-gpne.fr
+33149203040
Sarah ABRAMOWICZ, MD
Contact
sarah.abramowicz@ght-gpne.fr
+33149203040

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion